BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 10649245)

  • 21. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
    Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
    Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
    Lamerz R; Runge M; Stieber P; Meissner E
    Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC).
    Murakami N; Tamano M; Yoneda M; Sugaya H; Hiraishi H
    Hepatogastroenterology; 2008; 55(81):197-201. PubMed ID: 18507106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
    Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T
    J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.
    Okuda H; Saito A; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2005 May; 20(5):759-64. PubMed ID: 15853991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study.
    Izuno K; Fujiyama S; Yamasaki K; Sato M; Sato T
    Hepatogastroenterology; 1995; 42(4):387-93. PubMed ID: 8586374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.
    Bertino G; Ardiri AM; Boemi PM; Ierna D; Interlandi D; Caruso L; Minona E; Trovato MA; Vicari S; Li Destri G; Puleo S
    Panminerva Med; 2008 Sep; 50(3):221-6. PubMed ID: 18927526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2002 Jul; 17(7):772-8. PubMed ID: 12121507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.
    Bertino G; Ardiri AM; Calvagno GS; Bertino N; Boemi PM
    Drug News Perspect; 2010 Oct; 23(8):498-508. PubMed ID: 21031166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation assays as diagnostic markers of hepatocellular carcinoma.
    Lefrère JJ; Conard J; Mavier P; Bettan L; Beaugrand M; Gozin D; Lerable J; Dhumeaux D; Samama M
    Thromb Haemost; 1988 Dec; 60(3):468-70. PubMed ID: 2467402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma.
    Mita Y; Aoyagi Y; Yanagi M; Suda T; Suzuki Y; Asakura H
    Cancer; 1998 May; 82(9):1643-8. PubMed ID: 9576283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
    Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
    Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H; Kumada T; Osaki Y; Oka H; Urano F; Kudo M; Matsunaga T
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1528-36. PubMed ID: 17162244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
    Fujiyama S; Morishita T; Shibata J; Sato T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
    Shimada M; Yonemura Y; Ijichi H; Harada N; Shiotani S; Ninomiya M; Terashi T; Yoshizumi T; Soejima Y; Maehara Y
    Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
    Ishida H; Matsuo S; Inoue Y
    Rinsho Byori; 2010 Nov; 58(11):1065-72. PubMed ID: 21229703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1290-6. PubMed ID: 11903749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.